生命科学资讯

Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges

Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

Charles River to close cell therapy CDMO site, lay off 20 staffers

'Turning around the Titanic': How the incoming PBM reforms will transform CMS

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail

Illumina Collaborates with San Diego Zoo Wildlife Alliance to Sequence the - BIOENGINEER.ORG

Pfizer dips on new data for obesity drug acquired in $10B deal

Switching off resistance: Lixa’s bold AMR bet

Why many global drugs never reach Japan

China NMPA approves Sciwind’s GLP-1 injection for diabetes

Elevar gets new CEO, files NDAs for lirafugratinib, rivoceranib

Amgen quits Kyowa Kirin deal, returns rocatinlimab

What's driving health tech M&A

China startup AccurEdit raises $75M for gene editing therapies